5-aza-2′-deoxycytidine enhances the radiosensitivity of breast cancer cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 1, 2013, Pages 34-44

  Wang, Li ^a   Zhang, Yong ^b   Li, RongQing ^b   Chen, Yue ^a   Pan, XinYan ^a   Li, GuiYun ^a   Dai, Fang ^a   Yang, JuLun ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; DAC; Radiosensitivity; Radiotherapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5 AZA 2' DEOXYCYTIDINE; BRCA1 PROTEIN; HISTONE H2AX; MESSENGER RNA; PROTEIN 14 3 3; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DEMETHYLATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; IRRADIATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METHYLATION; SILENT GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AZACITIDINE; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84872189951     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1170     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69
2. Whelan TJ, Pignol JP, Levine MN, et al. Long-Term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513
3. Esteller M. Epigenetics in cancer. N Engl J Med 2008 358:1148
4. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010;70:27
5. Schubeler D. Epigenomics: Methylation matters. Nature 2009;462:296
6. Tycko B. Cancer epigenetics and targeted therapies. Oncology (Williston Park) 2011;25:228
7. Mund C, Hackanson B, Stresemann C, et al. Characterization of DNA demethylation effects induced by 5-Aza-2¢-deoxycytidine in patients with myelodysplastic syndrome. Cancer Res 2005;65:7086
8. Zhang B, Huang T, Liu K, et al. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene. J Huazhong Univ Sci Technolog Med Sci 2007;27:543
9. Mirza S, Sharma G, Pandya P, et al. Demethylating agent 5-Aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Mol Cell Biochem 2010 342:101
10. Sandhu R, Rivenbark AG, Coleman WB. Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b. Breast Cancer Res Treat 2012;131:385
11. Xu J, Zhou JY, Tainsky MA, et al. Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2¢- deoxycytidine sensitizes human breast cancer cells to adriamycin. Cancer Res 2007;67:1203
12. Cho HJ, Kim SY, Kim KH, et al. The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol 2009;7:49
13. Qiu H, Yashiro M, Shinto O, et al. DNA methyltransferase inhibitor 5-Aza-CdR enhances the radiosensitivity of gastric cancer cells. Cancer Sci 2009;100:181
14. Dote H, Cerna D, Burgan WE, et al. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Clin Cancer Res 2005;11:4571
15. De Schutter H, Kimpe M, Isebaert S, et al. A systematic assessment of radiation dose enhancement by 5-Aza-2¢-deoxycytidine and histone deacetylase inhibitors in headand-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009;73:904
16. Nicoll G, Crichton DN, McDowell HE, et al. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer 2001;85:1878
17. Nome RV, Bratland A, Harman G, et al. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. Mol Cancer Ther 2005 4:1231
18. Blakely EA. Radiation-induced changes in a cell's program for life. Acta Oncol 1998;37:127
19. Yang X, Phillips DL, Ferguson AT, et al. Synergistic activation of functional estrogen receptor (ER)-Alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-Alpha-negative breast cancer cells. Cancer Res 2001;61:7025
20. Fan J, Yin WJ, Lu JS, et al. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. J Cancer Res Clin Oncol 2008;134:883
21. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:928
22. Zhang Y, Chen LH, Wang L, et al. Radiation-inducible PTEN expression radiosensitises hepatocellular carcinoma cells. Int J Radiat Biol 2010;86:964
23. Sakakura C, Miyagawa K, Fukuda KI, et al. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 2007;26:5927
24. Roy K, Wang L, Makrigiorgos GM, et al. Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun 2006;344:821
25. Wei M, Grushko TA, Dignam J, et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 2005;65:10692
26. Palii SS, Van Emburgh BO, Sankpal UT, et al. DNA methylation inhibitor 5-Aza-2¢-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol 2008;28:752
27. Martin NT, Nahas SA, Tunuguntla R, et al. Assessing ''radiosensitivity'' with kinetic profiles of gamma-H2AX, 53BP1 and BRCA1 foci. Radiother Oncol 2011;101:35
28. Qi W, Martinez JD. Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiat Res 2003;160:217
29. Ferguson AT, Evron E, Umbricht CB,, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000;97:6049
30. Graff JR, Herman JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195
31. Nam JS, Ino Y, Kanai Y, et al. 5-Aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin Exp Metastasis 2004;21:49
32. Theys J, Jutten B, Habets R, et al. E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 2011;99:392
33. Garcia JS, Jain N, Godley LA. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. Onco Targets Ther 2010;3:1-13
34. Yoo CB, Jeong S, Egger G, et al. Delivery of 5-Aza-2¢-deoxycytidine to cells using oligodeoxynucleotides. Cancer Res 2007;67:6400